EEF1A1 and cancer: These findings support the notion that targeting the methyltransferases responsible for EEF1A1 methylation is a viable strategy to disrupt protein synthesis in a cancer-specific manner and impede the growth of DMG cells as part of a multi-agent approach to therapy.